Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
SigmaStar Technology
301536
Jiangsu Jingxue Insulation Technology
301010
CN Stock MarketDetailed Quotes
300289 Beijing Leadman Biochemistry
- 5.60
- +0.06+1.08%
Noon Break Dec 18 11:30 CST
3.05BMarket Cap-400.00P/E (TTM)
5.64High5.37Low48.07KlotVolume5.53Open5.54Pre Close26.41MTurnover0.89%Turnover Ratio200.00P/E (Static)544.01MShares6.3752wk High1.75P/B3.04BFloat Cap3.4452wk Low6.65Limit Up543.16MShs Float30.76Historical High4.43Limit Down4.87%Amplitude3.44Historical Low0.01Dividend TTM5.49Avg Price22.13KlotAsk0.18%Div YieldTTM100Lot Size24.98KlotBid
Beijing Leadman Biochemistry News
Leadman: Supplemental Announcement on the Acquisition of Minority Shareholders\' Shares and Related Transactions of Holding Subsidiaries Desai Systems and Desai Products
Leadman: Announcement on the acquisition of minority shareholder shares and related transactions of the holding subsidiary Desai Systems and Desai Products
Leadman: 2021 Annual Equity Distribution Implementation Notice
Leadman: Announcement on 2021 Profit Distribution Plan
Leadman: Response Report to the Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets (Second Revised Draft)
Leadman: Zhongqin Wanxin Certified Public Accountants (Special General Partnership)'s response to the “Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets”
Leadman: 1-1 Prospectus (Application Draft)
Leadman: Zhongqin Wanxin Certified Public Accountants (Special General Partnership)'s response to the “Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets”
Leadman: Response Report to the Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets (Revised Draft)
Leadman: 1-1 Prospectus (Application Draft)
Leadman: 1-1 Prospectus (Application Draft)
Leadman: Response report to the audit inquiry letter on Beijing Leadman Biochemical Co., Ltd.'s application to issue shares to specific targets
Leadman: Zhongqin Wanxin Certified Public Accountants (Special General Partnership)'s response to the “Audit Inquiry Letter on Beijing Leadman Biochemical Co., Ltd.'s Application for Issuance of Shares to Specific Targets”
Leadman: 1-1 Prospectus (Application Draft)
Leadman: Audit inquiry letter on Beijing Leadman Biochemical Co., Ltd.'s application to issue shares to specific targets
Leadman: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
Leadman: 3-3 Listing Sponsorship Letter (Filing Draft)
Leadman: 1-1 Prospectus (Application Draft)
Leadman: 4-1 Legal Opinion (Report Draft)
Leadman: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)